Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly

Human Antibodies

Volumn 13, Issue 4, 2004, Pages 105-110

  Wang, Fei ^a   Ruther, Paul ^a   Jiang, Ivy ^a   Sawada Hirai, Ritsuko ^a   Sun, Shu Man ^a   Nedellec, Rebecca ^a,b   Morrow, Phillip R ^a   Kang, Angray S ^a  

^a AVANIR PHARMACEUTICALS   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Bacillus anthracis; Human monoclonal antibodies; Protective antigen

Indexed keywords

ANTHRAX TOXIN; ANTHRAX VACCINE; EPITOPE; IMMUNOGLOBULIN G1 ANTIBODY; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AVP 1C6; MONOCLONAL ANTIBODY AVP 21D9; MONOCLONAL ANTIBODY AVP 22G12; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANTHRAX; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; EPITOPE MAPPING; HUMAN; IN VITRO STUDY; MOLECULAR INTERACTION; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION;

EID: 13444257711     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2004-13402     Document Type: Article

References (18)

1. A. Friedlander, Anthrax, in: Textbook of military medicine: medical aspects of chemical and biological warfare, T.E. Sidell FR, D.R. Franz, eds, Walter Reed Army Medical Center: Washington, DC., pp. 467-478.
2. P. Mikesell, B.E. Ivins, J.D. Ristroph and T.M. Dreier, Evidence for plasmid-mediated toxin production in Bacillus anthracis, Infect Immun 39(1) (1983), 371-376.
3. R.E.F.D. Lincoln, Anthrax toxin, in: Microbial toxins, K.S. Montie T and S.J. Ajl, eds, Academic Press, Inc: New York NY., pp. 319-414.
4. K.A. Bradley, J. Mogridge, M. Mourez, R.J. Collier and J.A. Young, Identification of the cellular receptor for anthrax toxin, Nature 414(6860) (2001), 225-229.
5. H.M. Scobie, G.J. Rainey, K.A. Bradley and J.A. Young, Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor, Proc Natl Acad Sci USA 100(9) (2003), 5170-5174.
6. E. Santelli, L.A. Bankston, S.H. Leppla and R.C. Liddington, Crystal structure of a complex between anthrax toxin and its host cell receptor, Nature 430(7002) (2004), 905-908.
7. A. Agrawal, J. Lingappa, S.H. Leppla, S. Agrawal, A. Jabbar, C. Quinn and B. Pulendran, Impairment of dendritic cells and adaptive immunity by anthrax lethal toxin, Nature 424(6946) (2003), 329-334.
8. J.C. Milne, D. Furlong, P.C. Hanna, J.S. Wall and R.J. Collier, Anthrax protective antigen forms oligomers during intoxication of mammalian cells, J Biol Chem 269(32) (1994), 20607-20612.
9. N.S. Duesbery, C.P. Webb, S.H. Leppla, V.M. Gordon, K.R. Klimpel, T.D. Copeland, N.G. Ahn, M.K. Oskarsson, K. Fukasawa, K.D. Paull and G.F. Vande Woude, Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor, Science 280(5364) (1998), 734-737.
10. W.E. Farrar, Anthrax: virulence and vaccines, Ann Intern Med 121(5) (1994), 379-380.
11. S.F. Little, S.H. Leppla and E. Cora, Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin, Infect Immun 56(7) (1988), 1807-1813.
12. S.F. Little, S.H. Leppla and A.M. Friedlander, Production and characterization of monoclonal antibodies against the lethal factor component of Bacillus anthracis lethal toxin, Infect Immun 58(6) (1990), 1606-1613.
13. S.F. Little, B.E. Ivins, P.F. Fellows and A.M. Friedlander, Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs, Infect Immun 65(12) (1997), 5171-5175.
14. V.A. Karginov, T.M. Robinson, J. Riemenschneider, B. Golding, M. Kennedy, J. Shiloach and K. Alibek, Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis, FEMS Immunol Med Microbiol 40(1) (2004), 71-74.
15. R. Sawada-Hirai, I. Jiang, F. Wang, S.M. Sun, R. Nedellec, P. Ruther, A. Alvarez, P.R. Morrow and A.S. Kang, Human Anti-Anthrax Protective Antigen Neutralizing Monoclonal Antibodies Derived From Donors Vaccinated With Anthrax Vaccine Adsorbed, J Immune Based Therapies and Vaccines 2 (2004), 5.
16. S.L. Welkos, J.R. Lowe, F. Eden-McCutchan, M. Vodkin, S.H. Leppla and J.J. Schmidt, Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis, Gene 69(2) (1988), 287-300.
17. J.M. Novak, M.P. Stein, S.F. Little, S.H. Leppla and A.M. Friedlander, Functional characterization of protease-treated Bacillus anthracis protective antigen, J Biol Chem 267(24) (1992), 17186-17193.
18. J. Mogridge, M. Mourez and R.J. Collier, Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin, J Bacteriol 183(6) (2001), 2111-2116.